Inhibition of invasion-associated thromboxane synthase sensitizes experimental gliomas to γ-radiation

Journal of Neuro-Oncology

Volumn 91, Issue 3, 2009, Pages 241-249

  Schauff, Anne Katrin ^a   Kim, Ella L ^b   Leppert, Jan ^c   Nadrowitz, Roger ^c   Wuestenberg, Robin ^d   Brockmann, Mark Alexander ^e   Giese, Alf ^b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d PIUS HOSPITAL   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Glioma; Invasion; Radiation; Radiation sensitizer; Thromboxane synthase

Indexed keywords

FUREGRELATE; THROMBOXANE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; COLONY FORMATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; GAMMA RADIATION; GLIOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOTHERAPY; MOUSE; NONHUMAN; RADIATION DOSE; RADIOSENSITIVITY; RADIOSENSITIZATION; TREATMENT RESPONSE; TUMOR VOLUME;

ANIMALS; ANIMALS, INBRED STRAINS; ASTROCYTES; BENZOFURANS; BRAIN NEOPLASMS; CELL SURVIVAL; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; ENZYME INHIBITORS; GAMMA RAYS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MICE; NEOPLASM INVASIVENESS; RADIATION TOLERANCE; THROMBOXANE-A SYNTHASE; THROMBOXANES; TIME FACTORS; TRANSFECTION;

EID: 58149475236     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-008-9708-0     Document Type: Article

References (34)

1. Bennett A (1986) The production of prostanoids in human cancers, and their implications for tumor progression. Prog Lipid Res 25:539-542. doi: 10.1016/0163-7827(86)90109-8
2. Giese A, Hagel C, Kim EL et al (1999) Thromboxane synthase regulates the migratory phenotype of human glioma cells. Neuro-oncol 1:3-13. doi: 10.1215/15228517-1-1-3
3. Kürzel F, Hagel C, Zapf S et al (2002) Cyclooxygenase inhibitors and thromboxane synthase inhibitors differentially regulate migration arrest, proliferation, and apoptosis in human glioma cells. Acta Neurochir (Wien) 144:71-87. doi: 10.1007/s701-002-8276-9
4. Pradono P, Tazawa R, Maemondo M et al (2002) Gene transfer of thromboxane A(2) synthase and prostaglandin I(2) synthase antithetically altered tumor angiogenesis and tumor growth. Cancer Res 62:63-66
5. McDonough W, Tran N, Giese A et al (1998) Altered gene expression in human astrocytoma cells selected for migration. I. Thromboxane synthase. J Neuropathol Exp Neurol 55:449-455. doi: 10.1097/ 00005072-199805000-00008
6. Rodrigues S, Nguyen QD, Faivre S et al (2001) Activation of cellular invasion by trefoil peptides and src is mediated by cyclooxygenase- and thromboxane A2 receptor-dependent signaling pathways. FASEB J 15:1517-1528. doi: 10.1096/fj.00-0802com
7. Yoshizato K, Zapf S, Westphal M et al (2002) Thromboxane synthase inhibitors induces apoptosis in migration arrested glioma cells. Neurosurgery 50:343-354. doi: 10.1097/00006123-200202000-00021
8. Kim EL, Meissner H, Warneke G et al (2003) Regulation of thromboxane synthase by tumor suppressor p53 and ets-1. Oncogene 22:7716-7727. doi: 10.1038/sj.onc.1207155
9. Giese A, Rief MD, Loo MA et al (1994) Determinants of human astrocytoma migration. Cancer Res 54:3897-3904
10. Jantke J, Kim E, Kürzel F et al (2004) Inhibition of the arachidonic acid metabolism blocks endothelial cell migration and induces apoptosis. Acta Neurochir (Wien) 146:483-494. doi: 10.1007/ s00701-004-0238-z
11. Aragane Y, Kulms D, Metze D et al (1998) Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L. J Cell Biol 140:171-182. doi: 10.1083/jcb.140.1.171
12. Kim EL, Yoshizato K, Meissner H et al (2005) Comparative assessment of status and function of p53 in human glioma cells. Anticancer Res 25:213-224
13. Brockmann MA, Westphal M, Lamszus K (2003) Improved method for the intracerebral engraftment of tumour cells and intratumoural treatment using a guide screw system in mice. Acta Neurochir (Wien) 145:777-781. doi: 10.1007/s00701-003-0091-5
14. Brockmann MA, Ulmer S, Leppert J et al (2006) Analysis of mouse brain using a clinical 1.5 Tesla scanner and a standard small loop surface coil. Brain Res 1068:138-142. doi: 10.1016/j.brainres.2005.10.098
15. Gaffney DK, Holden J, Davis M et al (2001) Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy. Int J Radiat Oncol Biol Phys 49:1213-1217. doi: 10.1016/S0360-3016(00)01583-2
16. Liao Z, Komaki R, Mason KA et al (2003) Role of cyclooxygenase-2 inhibitors in combination with radiation therapy in lung cancer. Clin Lung Cancer 4:356-365
17. Terakado N, Shintani S, Yano J et al (2004) Overexpression of cyclooxygenase-2 is associated with radioresistance in oral squamous cell carcinoma. Oral Oncol 40:383-389. doi: 10.1016/ j.oraloncology.2003.09.005
18. Nix P, Lind M, Greenman J et al (2004) Expression of Cox-2 protein in radioresistant laryngeal cancer. Ann Oncol 15:797-801. doi: 10.1093/ annonc/mdh185
19. Milas L (2003) Cyclooxygenase-2 (COX-2) enzyme inhibitors and radiotherapy: Preclinical basis. Am J Clin Oncol 26:66-69
20. Petersen C, Baumann M, Petersen S (2003) New targets for the modulation of radiation response-selective inhibition of the enzyme cyclooxygenase 2. Curr Med Chem Anticancer Agents 3:354-359. doi: 10.2174/ 1568011033482314
21. Liu W, Chen Y, Wang W et al (2003) Combination of radiation and Celebrex (celecoxib) reduce mammary and lung tumor growth. Am J Clin Oncol 26:103-109. doi: 10.1097/00000421-200306000-00015
22. Williams CS, Watson AJ, Sheng H et al (2000) Celecoxib prevents tumor growth in vivo without toxicity to normal gut: Lack of correlation between in vitro and in vivo models. Cancer Res 60:6045-6051
23. Raju U, Nakata E, Yang P et al (2002) In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerations. Int J Radiat Oncol Biol Phys 54:886-894. doi: 10.1016/S0360-3016(02)03023-7
24. Nakata E, Mason KA, Hunter N et al (2004) Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors. Int J Radiat Oncol Biol Phys 58:369-375. doi: 10.1016/ j.ijrobp.2003.09.061
25. Tegeder I, Pfeilschifter J, Geisslinger G (2001) Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J 15:2057-2072. doi: 10.1096/fj.01-0390rev
26. Nie D, Che M, Zacharek A et al (2004) Differential expression of thromboxane synthase in prostate carcinoma: Role in tumor cell motility. Am J Pathol 164:429-439
27. Moussa O, Yordy JS, Abol-Enein H et al (2005) Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer. Cancer Res 65:11581-11587. doi: 10.1158/ 0008-5472.CAN-05-1622
28. Watkins G, Douglas-Jones A, Mansel RE et al (2005) Expression of thromboxane synthase, TBXAS1 and the thromboxane A2 receptor, TBXA2R, in human breast cancer. Int Semin Surg Oncol 2:23. doi: 10.1186/ 1477-7800-2-23
29. Dassesse T, de Leval X, de Leval L et al (2006) Activation of the thromboxane A2 pathway in human prostate cancer correlates with tumor Gleason score and pathologic stage. Eur Urol 50:1021-1031. doi: 10.1016/ j.eururo.2006.01.036
30. Sakai H, Suzuki T, Takahashi Y et al (2006) Upregulation of thromboxane synthase in human colorectal carcinoma and the cancer cell proliferation by thromboxane A2. FEBS Lett 580:3368-3374. doi: 10.1016/ j.febslet.2006.05.007
31. Reardon DA, Rich JN, Friedman HS et al (2006) Recent advances in the treatment of malignant astrocytoma. J Clin Oncol 24:1253-1265. doi: 10.1200/JCO.2005.04.5302
32. Dittmer J (2003) The biology of the Ets1 proto-oncogene. Mol Cancer 2:29. doi: 10.1186/1476-4598-2-29
33. Gilliland DG et al (2001) The diverse roles of the ets family of transcription factor in cancer. Clin Cancer Res 7:451-453
34. Oikawa T (2004) ETS transcription factors: Possible targets for cancer therapy. Cancer Sci 95:626-633. doi: 10.1111/j.1349-7006.2004.tb03320.x